Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Gynecology | Nursing | Oncology | Journal

Back to Journal Articles

Considerable Regional Variation for Brachytherapy

Last Updated: October 26, 2012.

 

Women treated with brachytherapy experience more overall, wound, skin complications

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
A considerable proportion of Medicare beneficiaries are treated with brachytherapy for breast cancer, with substantial regional variation, according to a study published online Oct. 22 in the Journal of Clinical Oncology.

FRIDAY, Oct. 26 (HealthDay News) -- A considerable proportion of Medicare beneficiaries are treated with brachytherapy for breast cancer, with substantial regional variation, according to a study published online Oct. 22 in the Journal of Clinical Oncology.

Carolyn J. Presley, M.D., from Yale University in New Haven, Conn., and colleagues examined brachytherapy treatment patterns and associated complications in a national sample of Medicare beneficiaries aged 66 to 94 years who underwent breast-conserving surgery from 2008 to 2009 and were treated with brachytherapy or whole breast irradiation (WBI). National treatment variation was assessed using hospital referral regions (HRRs). Complications were compared for brachytherapy and WBI at one year of follow-up.

The researchers found that 15.8 percent of 29,648 women received brachytherapy, with the percentage of women receiving brachytherapy varying from 0 to over 70 percent by HRR. Significantly more women treated with brachytherapy had a complication (34.3 percent), compared with women treated with WBI (18.4 percent). There was a 16.9 percent higher rate of wound and skin complications for women treated with brachytherapy, compared with WBI, but no difference in deep-tissue and bone complications.

"The marked regional variation in utilization suggests that nonclinical factors play an important role in its dissemination," the authors write. "Given the higher costs associated with brachytherapy, the higher risk of complications suggests that clinicians, patients, and policy makers should closely scrutinize the use of this treatment modality."

Two authors disclosed financial ties to Cianna Medical, Fair Health, and/or Medtronic.

Abstract
Full Text (subscription or payment may be required)
Editorial

Copyright © 2012 HealthDay. All rights reserved.


Previous: Brain Volume Rebounds Within Days of Alcohol Abstinence Next: American Academy of Pediatrics, Oct. 20-23, 2012

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.